- NSE
- APLLTD
- BSE
- 533573
- ISIN
- INE901L01018
ALEMBIC PHARMA
Healthcare· Pharmaceuticals & Biotechnology· Pharmaceuticals
₹1,017.30
+₹52.15 (+5.40%)
NSE close ·
ALEMBIC PHARMA closed at ₹1,017.30 on 9 Nov 2026, up 5.40% on the day, and is up 10.34% over the past year.
Price history
Between 10 Nov 2025 and 9 Nov 2026, the closing price ranged from ₹646.55 to ₹1,017.30.
Price returns, excl. dividends. 3Y, 5Y and Max are annualised.
Fundamentals
- Market cap
- ₹19,996 Cr
- P/E (TTM)
- 23.7
- Industry P/E
- 35.5
- EPS (TTM)
- ₹42.92
- P/B
- 3.36
- Book value
- ₹302.42
- ROE
- 14.2%
- ROCE
- 14.2%
- Debt/equity
- 0.25
- Operating margin
- 11.6%
- Net margin
- 9.9%
- Dividend yield
- 1.18%
Market cap, P/E, P/B and yield at the 9 Nov 2026 close. TTM: four quarters to 30 Sep 2026 (consolidated). Balance sheet 30 Sep 2026. Industry P/E is the median of 21 Pharmaceuticals & Biotechnology stocks.
Quarterly results
| Growth | 1Y | 3Y CAGR |
|---|---|---|
| Revenue | +20.05% | +12.40% |
| Net profit | +32.94% | +16.46% |
Trailing twelve months against the same period 1 and 3 years earlier (3Y as a yearly rate); consolidated.
| Quarter | Revenue | Net profit | YoY profit | EPS |
|---|---|---|---|---|
| Sep 2026 | ₹2,619 Cr | ₹334 Cr | +81.76% | ₹17.05 |
| Jun 2026 | ₹2,165 Cr | ₹172 Cr | +12.19% | ₹8.80 |
| Mar 2026 | ₹1,873 Cr | ₹202 Cr | +28.67% | ₹10.31 |
| Dec 2025 | ₹1,892 Cr | ₹132 Cr | −4.17% | ₹6.76 |
| Sep 2025 | ₹1,917 Cr | ₹184 Cr | +19.96% | ₹9.40 |
| Jun 2025 | ₹1,717 Cr | ₹154 Cr | +14.19% | ₹7.85 |
| Mar 2025 | ₹1,784 Cr | ₹157 Cr | −12.11% | ₹7.98 |
| Dec 2024 | ₹1,702 Cr | ₹138 Cr | −23.70% | ₹7.01 |
Armor risk check
ALEMBIC PHARMA moves about 2× as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appFAQs
What is ALEMBIC PHARMA's share price today?
ALEMBIC PHARMA (NSE: APLLTD) closed at ₹1,017.30 on 9 Nov 2026, up 5.40% from the previous close of ₹965.15. It traded between ₹1,006.30 and ₹1,055.70 that day.
What are ALEMBIC PHARMA's 52-week high and low?
Over the last 52 weeks ALEMBIC PHARMA traded between ₹635.80 and ₹1,055.70, adjusted for splits and bonuses.
What are ALEMBIC PHARMA's NSE symbol, BSE code and ISIN?
ALEMBIC PHARMA has NSE symbol APLLTD, BSE code 533573, ISIN INE901L01018.
How has ALEMBIC PHARMA performed over 1, 3 and 5 years?
ALEMBIC PHARMA's share price return: 1Y +10.34%, 3Y +11.48% a year, 5Y +5.45% a year. Dividends are not included.
Does ALEMBIC PHARMA pay a dividend?
Yes. ALEMBIC PHARMA's latest dividend went ex on 29 Jul 2026: Final · ₹12.00 per share. Dividends over the past year come to a yield of 1.18% at the latest close.
What is ALEMBIC PHARMA's P/E ratio?
ALEMBIC PHARMA's P/E ratio is 23.7: the ₹1,017.30 close on 9 Nov 2026 over trailing twelve-month EPS of ₹42.92 (consolidated, four quarters to 30 Sep 2026).
What is ALEMBIC PHARMA's market cap?
ALEMBIC PHARMA's market cap is ₹19,996 Cr at the close on 9 Nov 2026.
Which sector is ALEMBIC PHARMA in?
ALEMBIC PHARMA is in NSE's Healthcare sector, in the Pharmaceuticals & Biotechnology industry (Pharmaceuticals).
For information only. Not investment advice or a research report. Past performance does not guarantee future returns.
Full disclaimerSee how ALEMBIC PHARMA fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app